Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ipratropium Bromide Versus Short Acting Beta-2 Agonists for Stable Chronic Obstructive Pulmonary Disease." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451482/all/Ipratropium_bromide_versus_short_acting_beta_2_agonists_for_stable_chronic_obstructive_pulmonary_disease.
Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451482/all/Ipratropium_bromide_versus_short_acting_beta_2_agonists_for_stable_chronic_obstructive_pulmonary_disease. Accessed April 17, 2025.
Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451482/all/Ipratropium_bromide_versus_short_acting_beta_2_agonists_for_stable_chronic_obstructive_pulmonary_disease
Ipratropium Bromide Versus Short Acting Beta-2 Agonists for Stable Chronic Obstructive Pulmonary Disease [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 April 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451482/all/Ipratropium_bromide_versus_short_acting_beta_2_agonists_for_stable_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease
ID - 451482
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451482/all/Ipratropium_bromide_versus_short_acting_beta_2_agonists_for_stable_chronic_obstructive_pulmonary_disease
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -